about
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions...
Read More
4.86
0.29
(6.35%)
237.6K
XNAS Volume
XNAS 21 Sep, 2026 10:02 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Synaptogenix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..